The prevention and management of chronic kidney disease among patients with metabolic syndrome
<p>Treatment of patients with chronic kidney disease (CKD) requires implementation of prevention and management strategies that reduce the risk of kidney failure and CKD-associated cardiovascular risk. Metabolic syndrome is characterised by obesity, high blood pressure, dyslipidaemia and hyper...
Main Authors: | Zhu, D, Judge, PK, Wanner, C, Haynes, R, Herrington, WG |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2024
|
Subjects: |
Similar Items
-
Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study
by: Plewes, Katherine, et al.
Published: (2017) -
The association of sleep duration with the risk of chronic kidney disease: a systematic review and meta-analysis
by: Koh, Jin Hean, et al.
Published: (2024) -
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial
by: Mayne, K, et al.
Published: (2024) -
Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients
by: Ong, Sean Wei Xiang, et al.
Published: (2022) -
Effectiveness of a chronic obstructive pulmonary disease integrated care pathway in a regional health system : a propensity score matched cohort study
by: Wu, Christine Xia, et al.
Published: (2018)